comparemela.com

Latest Breaking News On - Clinical global impression - Page 10 : comparemela.com

Second-Generation Monarch eTNS System Cleared for Pediatric ADHD

The FDA has cleared NeuroSigma’s second-generation Monarch eTNS System to treat ADHD in patients 7 to 12 years of age.

Transcranial Electrical Stimulation Effective for Insomnia

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.